Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Medical Therapy vs. Carotid Endarterectomy in Patients with Asymptomatic Carotid Stenosis
    STROKE ALERT

    Medical Therapy vs. Carotid Endarterectomy in Patients with Asymptomatic Carotid Stenosis

    January 1, 2021
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Carotid Endarterectomy vs. Medical Therapy in Patients with Asymptomatic Carotid Stenosis

    Carotid Occlusion Rarely Develops from Asymptomatic Carotid Artery Stenosis

    Carotid Stenting vs. Endarterectomy for Symptomatic Stenosis: Endarterectomy Remains the Gold Standard

    Related Products

    Carotid Occlusion Rarely Develops from Asymptomatic Carotid Artery Stenosis

    Symptomatic Carotid Artery Stenosis Requires Urgent Revascularization

    Bright-light Therapy for Daytime Sleepiness in Parkinson’s Disease Patients

    Keywords

    artery

    stroke

    carotid

    stenosis

    endarterectomy

    By Matthew E. Fink, MD

    Louis and Gertrude Feil Professor and Chair, Department of Neurology, Associate Dean for Clinical Affairs, New York Presbyterian/Weill Cornell Medical College

    Dr. Fink reports no financial relationships relevant to this field of study.

    SOURCE: Keyhani S, Cheng EM, Hoggatt KJ, et. al. Comparative effectiveness of carotid endarterectomy vs initial medical therapy in patients with asymptomatic carotid stenosis. JAMA Neurology 2020;77:1110-1121.

    It has been more than 25 years since patients who had asymptomatic carotid artery stenosis were studied and followed. Since the pivotal trials demonstrating the benefit of endarterectomy vs. medical therapy many years ago,1,2 there has been significant improvement in the risk factors for atherosclerosis, including better treatment of blood pressure and diabetes, as well as improved antiplatelet medication regimens and high-potency statins.

    In this real-world comparative effectiveness study, data were mined from several large databases of prospectively collected information on patients followed by the Department of Veterans Affairs (VA). This included both VA records data as well as Medicare data. This study was conducted from 2018-2020, and the data were analyzed of those veterans aged 65 years or older who had carotid imaging between Jan. 1, 2005, and Dec. 31, 2009.

    Patients who had carotid stenosis of 50% or greater and were treated with medical therapy or carotid endarterectomy were followed for five years. Survival curves were computed to estimate the risk of fatal and nonfatal strokes in each cohort, and outcomes were calculated for each group and compared. The sample then was restricted to patients who would meet criteria for a randomized controlled trial and compared once again.

    Of 5,221 patients, 51.9% underwent carotid endarterectomy (mean age 73.6 years, 98.8% were men) and 48.1% received initial medical therapy (mean age 73.6 years, 98.8% men). In the group that underwent carotid endarterectomy, the 30-day, perioperative rate of stroke or death was 2.5%. Overall, the five-year risk of fatal and nonfatal strokes was lower in the patients randomized to carotid endarterectomy compared with patients randomized to medical therapy (5.6% vs. 7.8%). However, when incorporating the risk of death, the risk difference between the two cohorts after five years was not significantly different, primarily because of the upfront risk of perioperative stroke and death in the group that underwent carotid endarterectomy. The absolute risk reduction of endarterectomy was less than half of what was reported in studies from the 1990s — 0.46% per year, with number needed to treat of 43 to reduce one stroke over five years. This lack of difference is attributed to improved medical therapy.

    At the present time, the benefit of carotid endarterectomy in asymptomatic patients with carotid artery stenosis ≥ 50% is questionable, and most patients will benefit from medical treatment.

    REFERENCES

    1. Hobson RW 2nd, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med 1993;328:221-227.
    2. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004;363:1491-1502.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert (Vol. 40, No. 5) - January 2021
    January 1, 2021

    Table Of Contents

    Neurotropism of COVID-19: What Is New?

    Cranial Neuropathy in CIDP

    Rapid Eye Movement Sleep Duration Is Predictive of Life Expectancy

    Rhabdomyolysis Etiology

    Medical Therapy vs. Carotid Endarterectomy in Patients with Asymptomatic Carotid Stenosis

    Ticagrelor, a New Antiplatelet Agent, Shows Promise in Secondary Prevention of Ischemic Stroke

    A Mobile Interventional Stroke Team (MIST) Shows Promise in Performing Rapid Thrombectomy

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Morrow Mark; and Accreditations Director Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2021 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing